Reaction

Granuloma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,414 reports · 140 co-occurring drugs

As of the last recalculation, Granuloma appears in 3,414 FAERS reports alongside 140 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 37.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dimenhydrinate	65	37.9	38.1
Febuxostat Tablets 40 Mg	60	36.6	36.8
Febuxostat Tablets 80 Mg	60	36.6	36.8
Pyrazinamide	49	32.3	32.4
Rifampicin	50	30.6	30.7
Ciclesonide	61	27.8	27.9
Isoniazid	69	26.5	26.6
Theophylline Anhydrous	49	24.4	24.5
Theophylline	43	23.1	23.2
Adalimumab-Fkjp	167	23.1	23.1
Febuxostat	61	22.6	22.7
Adalimumab-Aaty	167	22.6	22.6
Adalimumab-Adaz	167	20.2	20.3
Valganciclovir Hydrochloride Powder,	32	16.1	16.2
Rifampin	38	16.0	16.1
Bupivacaine	24	15.8	15.8
Colchicine	66	15.6	15.6
Risedronate Sodium	72	14.4	14.4
Fluticasone Furoate	28	14.2	14.2
Basiliximab	27	14.1	14.1
Amphotericin B	27	13.2	13.3
Ipratropium Bromide	69	12.0	12.0
Ibuprofen And Diphenhydramine Citrate	45	11.9	12.0
Diphenhydramine Hydrochloride Capsule, Liquid Filled	41	11.8	11.9
Valganciclovir	36	11.8	11.8
Valganciclovir Hydrochloride	36	11.8	11.8
Esomeprazole Magnesium Capsule, Delayed Release	27	11.4	11.4
Esomeprazole Magnesium Delayed Release Capsules	27	11.4	11.4
Esomeprazole Magnesium Dihydrate	27	11.4	11.4
Daspone	17	10.7	10.7
Dapsone Gel, 5%	17	10.7	10.7
Efavirenz	19	10.4	10.5
Alendronate Sodium	162	10.2	10.2
Calcitriol Capsules 0.25 Mcg	32	9.8	9.8
Calcitriol Capsules 0.5 Mcg	32	9.8	9.8
Dapsone	17	9.8	9.8
Calcitriol	32	9.7	9.7
Leflunomide	159	9.7	9.7
Voriconazole Injection	34	9.6	9.6
Bleomycin Sulfate	16	9.5	9.5
Itraconazole	18	9.4	9.5
Dexlansoprazole	63	9.4	9.4
Zidovudine	20	9.2	9.2
Nystatin Ointment	39	9.2	9.2
Nystatin Cream	39	9.1	9.2
Anti-Thymocyte Globulin (Rabbit)	12	9.1	9.1
Mycophenilic Acid	30	8.9	8.9
Nystatin	39	8.8	8.8
Azathioprine	122	8.7	8.7
Sulfasalazine	107	8.6	8.6
Lamivudine	42	8.4	8.4
Valsartan And Hydrochlorothiazide	17	7.7	7.7
Cyclosporine	134	7.6	7.6
Tacrolimus Ointment 0.1%	144	7.3	7.3
Tacrolimus Extended-Release Capsules	144	7.3	7.3
Voriconazole	36	7.3	7.3
Sirolimus	16	7.3	7.3
Lamivudine Oral	29	7.0	7.0
Infliximab	229	6.8	6.8
Hydroxychloroquine	81	6.8	6.8
Mycophenolic Acid	35	6.7	6.7
Valsartan Oral	59	6.7	6.7
Mycophenolate Mofetil	144	6.7	6.7
Mycophenolate Mofetil Hydrochloride	144	6.7	6.7
Tacrolimus	164	6.7	6.7
Rabeprazole	24	6.6	6.6
Cetirizine Hydrochloride Allergy	32	6.5	6.5
Cetirizine Hydrochloride Tablets	32	6.5	6.5
Naproxen	80	6.3	6.3
Hydroxychloroquine Sulfate	91	6.2	6.2
Irbesartan	44	6.1	6.1
Celecoxib	127	6.1	6.1
Rosuvastatin Calcium	27	5.9	5.9
Morphine	70	5.8	5.8
Methotrexate	360	5.7	5.7
Clarithromycin	31	5.5	5.6
Methotrexate Sodium	393	5.4	5.4
Prednisone	404	5.4	5.4
Rituximab	179	5.4	5.4
Prednisolone	153	5.4	5.4
Prednisolone Oral	153	5.4	5.4
Prednisolone Oral Solution	153	5.4	5.4
Estrogens, Conjugated	51	5.3	5.3
Golimumab	72	5.2	5.2
Conjugated Estrogens	49	5.2	5.2
Doxazosin Mesylate	29	4.9	4.9
Mepolizumab	39	4.8	4.8
Desoximetasone	15	4.8	4.8
Budesonide And Formoterol Fumarate Dihydrate	75	4.8	4.8
Losartan Potassium And Hydrochlorothiazide	9	4.7	4.7
Azithromycin	31	4.7	4.7
Duloxetine	53	4.7	4.7
Tocilizumab	84	4.6	4.6
Azithromycin Monohydrate	31	4.6	4.6
Ipilimumab	32	4.6	4.6
Fluticasone Propionate And Salmeterol Xinafoate	44	4.5	4.5
Certolizumab Pegol	84	4.5	4.5
Botulinum Toxin Type A	9	4.4	4.4
Abacavir Sulfate	7	4.4	4.4
Valsartan	73	4.3	4.3
Ustekinumab	71	4.3	4.3
Rabeprazole Sodium	19	4.3	4.3
Salmeterol Xinafoate	6	4.2	4.3
Doxazosin	19	4.2	4.2
Teduglutide	9	4.1	4.1
Secukinumab	105	4.1	4.1
Melphalan	15	4.0	4.0
Fulvestrant	20	3.7	3.7
Melphalan Hydrochloride	15	3.7	3.7
Lopinavir And Ritonavir	8	3.6	3.6
Icosapent Ethyl	5	3.6	3.6
Tobramycin	14	3.6	3.6
Lapatinib	9	3.5	3.5
Adalimumab	378	3.5	3.5
Nevirapine	5	3.4	3.4
Amikacin	9	3.2	3.2
Apremilast	76	3.2	3.2
Abatacept	71	3.2	3.2
Dabrafenib	10	2.9	2.9
Ado-Trastuzumab Emtansine	4	2.9	2.9
Tenofovir Disoproxil Fumarate Tablets	4	2.8	2.8
Pertuzumab	12	2.7	2.7
Conjugated Estrogens And Medroxyprogesterone Acetate	10	2.6	2.6
Erlotinib	4	2.5	2.5
Nivolumab	39	2.5	2.5
Budesonide, Glycopyrrolate, And Formoterol Fumarate	4	2.3	2.3
Trametinib	9	2.3	2.3
Tofacitinib	68	2.3	2.3
Faricimab	3	2.3	2.3
Methadone Hydrochloride	4	2.3	2.3
Pembrolizumab	35	2.0	2.0
Bendamustine Hydrochloride	4	2.0	2.0
Etanercept	194	2.0	2.0
Vemurafenib	4	2.0	2.0
Obinutuzumab	5	1.9	1.9
Encorafenib	3	1.8	1.8
Pseudoephedrine Hydrochloride	3	1.8	1.8
Leuprolide Acetate	22	1.7	1.7
Pseudoephedrine Hcl	3	1.7	1.7
Copper	4	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.